West Virginia Attorney General Patrick Morrisey said the state will receive more than $153,000 in a national settlement with a prescription drug manufacturer.
Morrisey says in a news release last month that every state and the District of Columbia are participating in the $13.5 million settlement with Boehringer Ingelheim Pharmaceuticals Inc.
The settlement resolves allegations that the company misrepresented the effectiveness of four drugs in treating or managing certain health conditions, including heart attacks, congestive heart failure and chronic obstructive pulmonary disease. The drugs are Micardis, Aggrenox, Atrovent and Combivent.
Topics Virginia
Was this article valuable?
Here are more articles you may enjoy.
Allstate CEO Wilson Takes on Affordability Issue During Earnings Call 
Florida’s Commercial Clearinghouse Bill Stirring Up Concerns for Brokers, Regulators 
Nine-Month 2025 Results Show P/C Underwriting Gain Skyrocketed 
Florida Insurance Costs 14.5% Lower Than Without Reforms, Report Finds 
